Systemic disease mini group

Published on Slideshow
Static slideshow
Download PDF version
Download PDF version
Embed video
Share video
Ask about this video

Scene 1 (0s)

Systemic disease mini group.

Scene 2 (6s)

Bacterial endo carditis. Microorganisms | Free Full-Text | Infective Endocarditis: A Focus on Oral Microbiota | HTML.

Scene 3 (25s)

Bacterial endo carditis. Infective Endocarditis | American Heart Association.

Scene 4 (41s)

British recommendations No prophylaxis.

Scene 5 (1m 5s)

Bacterial endo carditis. Protocol of management. PDF] Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young,.

Scene 6 (1m 35s)

Hypertension. Hypertension: Also known as high blood pressure is, by definition, a repeatedly elevated blood pressure exceeding 140 over 90 mmHg -- a systolic pressure above 140 or a diastolic pressure above 90. Chronic hypertension is a "silent" condition that does not have symptoms. It can cause blood vessel changes in the back of the eye (retina), abnormal thickening of the heart muscle, kidney failure, and brain damage. Hypertension is function of PR, Blood volume and Heart rate.

Scene 7 (1m 52s)

Category Normal Prehypertension Stage I Hypertension Stage II Hypertension Hypertensive Crisis Systolic (mm Hg) <120 120-139 140—159 2160-170 >180 and or or Diastolic (mm Hg) 80-89 2100-110 >110 Dental Management Considerations Routine dental management Recheck at continued-care (recare) visit Routine dental management Advise client of status; and recommend lifestyle management Recheck at recare visit Monitor blocxi pressure at consecutive appointments If all exceed these guidelines, seek medical consultation Stress-reduction protocol Recheck at recare visit Recheck blood pressure in 5 minutes If still elevated within this range, seek and receive medical consultation before dental hygiene therapy Noninvasive care only Definitive emergency care only if blood pressure is <180/110 Stress-reduction protocol Continue to monitor blood pressure at consecutive appointments Recheck at each visit Recheck blood pressure in 5 minutes If still elevated, immediate medical consultation is indicated No dental or dental hygiene care, elective or emergent, until blood pressure is decreased Noninvasive emergency care with drugs: analgesics or antibiotics are indicated Refer to hospital for immediate invasive dental care.

Scene 8 (3m 4s)

Coronary heart disease. Coronary heart disease is a type of heart disease that develops when the arteries of the heart cannot deliver enough oxygen-rich blood to the heart.

Scene 9 (3m 14s)

Myocardial infarction vs Angina Pectoris Main difference is permanent damage vs non permanent damage Primary diagnosis by medical history of more than 15 min attack.

Scene 10 (3m 45s)

Emergency MONA protocol Morphine Oxygen Nitroglycrine three times every 5 min Asprine 325-375 mg.

Scene 11 (4m 26s)

When to work Specially after 6 months of attack. Periodontal management of medically compromised patients - ppt video online download.

Scene 12 (4m 54s)

Heart Failure. New York Heart Association (NYHA) Heart Failure Symptom Classification... | Download Scientific Diagram.

Scene 13 (5m 27s)

Dental Consideration. Patients with CHF need special attention during dental care including avoiding procedures that can strain the heart, use of adequate pain control, monitoring blood pressure, shortened visits, and a cautious eye to possible complications. Patient must be treated in up right position to avoid dypnea.

Scene 14 (5m 37s)

Bleeding Problem. Physiology Vascular Mechanism Platelet Mechanism Coagulation a. Extrinsic (Fast and Week) b. intrinsic (Slow but definite).

Scene 15 (5m 56s)

Blood Coagulation and Blood–Material Interactions - ScienceDirect.

Scene 16 (6m 29s)

Tests to monitor coagulation. a-ug •zeo NIA III ue604'4* MåNH aavosvo Nouvnnovoo.

Scene 17 (6m 43s)

classification of Bleeding disorder. Bleeding disorders Coagulation factor deficiencies Congenital Fibrinolytic defects Streptokinase therapy Disseminated intravascular coagulation Acquired Vascular disorders Scurvy Purpura Hereditary hernorrhagic telangiectasia Cushing syndrome Ehlers-Danlos syndrome Platelet disorders Quantitative disorder (thrombocytopenia) Qualitative disorder.

Scene 18 (6m 51s)

Coagulation defect. Maybe congenital or acquired Congenital as hemophilia A, B or Von Willbrand disease Acquired Liver disease Oral Anticoagulant IV Anticoagulant.

Scene 19 (7m 1s)

Hemophilia. Defect in factor 8 or 9 based either A or B Monitored by PTT test and factor assey Mild forms with factor above 25% can be treated normally just inject tranexamic acid or aminocaproic acid prior to surgery IV Sever forms need replacement therapy either cryopreciptate , plasma or factor replacement under hospitalization Von Willbrand disease same management.

Scene 20 (7m 29s)

Acquired (Liver disease (Vitamin K related factors 1972).

Scene 21 (7m 55s)

Oral anti coagulant Warfarine. Mechanism of action : the block vitamin K epoxied reductase which is essential for formation of factor 7, 2. Monitored by PT and INR Test Management If PT and INR below double normal work normally If PT and INR above Double normal perform heparin shift with oral anticoagulant In Case of Emergency bleeding give vitamin K.

Scene 22 (8m 22s)

Interaction of Warfarine. H-2 Blockers Macrolide Antibiotics Metronidazole Quinolone Antibiotics Aspirine.

Scene 23 (8m 38s)

NOVAL oral anticoagulants. Factor specific group of drugs instead of Vitamin K epoxide reductase blockage Usually need no intervention.

Scene 24 (8m 51s)

IV anticoagulant. Heparin is the most famous drug Monitored by PTT test Interact with Active thrombine and active factor II and factor X 24 hour half life No specific antidote except factor replacement in emergency May consider Low molecular weight heparin shift and bridging in case of dental care Usually taken by post transplant patient and renal dialysis.

Scene 25 (9m 33s)

Fibrinolytic defect. DIC (Disseminated Intravascular Coagulopathy) Low platelet count associated Intravascular coagulopathy (COVID Vaccine) Pathophysiology Consumption of platelets by acute insult leading to generalized clots and emboli followed by bleeding due to consumption of bleeding coagulation factor Treatment Biggest struggle in medicine to weight anticoagulant with coagulant therapies.

Scene 26 (10m 13s)

Vascular problem. Scurvy Hereditary hemorrhagic telangiectasia Ehlers Danlos No Dental Consideration.

Scene 27 (10m 39s)

Platelet defect. Congenital Qualitative (Glanzmann disease, bernard soulier syndrome) Quantitively (Idiopathic thrombocytopenia) Common in females, associated with bruises and petechiae, and prolonged bleeding, autoimmune disease.

Scene 28 (10m 59s)

Test Bleeding Time Management. 3 Potential for Bleeding | Pocket Dentistry.

Scene 29 (11m 32s)

Acquired platelet defects. Plavix (Clopidogrel) Blocks platelets receptors ADP-induced platelet aggregation Aspirin block thromboxane A2 Both affect platelet irreversible so need at least 6-7 days to do dental work after termination of drug to allow sufficient platelet population In case of emergency perform heparin shift or platelet transfusin Monitoring by bleeding time.

Scene 30 (12m 5s)

Local Anticoagulant. Colla-Cote Tape, Plug Zimmer Dental Absorbable collagen dresslngs from b0',qne sourcg—can be sutured Into place, used under stents dentures or aloæ,• fully Shaped accordlrg to Intended Lße: •cote- % x 1.5 nch, 1 x 3 Inch,•, plug % x % Inch; all are supertor bermstats.